avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Cebpb
|
ENSMUSG00000056501.3 | CCAAT/enhancer binding protein (C/EBP), beta |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Cebpb | mm10_v2_chr2_+_167688915_167688973 | 0.09 | 5.9e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 8.2 | GO:0033189 | response to vitamin A(GO:0033189) |
2.6 | 5.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
2.1 | 8.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
1.7 | 8.6 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
1.7 | 5.0 | GO:0015866 | ADP transport(GO:0015866) |
1.0 | 3.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) calcium-independent cell-matrix adhesion(GO:0007161) cellular response to mercury ion(GO:0071288) |
0.9 | 2.8 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.9 | 3.7 | GO:0015851 | nucleobase transport(GO:0015851) pyrimidine nucleobase transport(GO:0015855) |
0.9 | 3.6 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.8 | 2.5 | GO:0010752 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) regulation of cGMP-mediated signaling(GO:0010752) |
0.8 | 4.6 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.7 | 12.0 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.7 | 5.8 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.7 | 8.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.7 | 1.4 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.6 | 1.8 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
0.6 | 2.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.6 | 2.2 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.6 | 2.2 | GO:0015827 | angiotensin-mediated drinking behavior(GO:0003051) aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.5 | 6.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.5 | 1.6 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.5 | 3.7 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.5 | 1.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.5 | 1.4 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.5 | 1.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 8.8 | GO:0051923 | sulfation(GO:0051923) |
0.4 | 1.6 | GO:0015825 | L-serine transport(GO:0015825) |
0.4 | 8.7 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.4 | 1.1 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
0.4 | 1.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.3 | 1.7 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.3 | 1.5 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.3 | 7.6 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.3 | 1.1 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.3 | 0.8 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.3 | 1.8 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.3 | 0.8 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.3 | 1.8 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.3 | 2.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.3 | 0.8 | GO:0010040 | GPI anchor release(GO:0006507) response to iron(II) ion(GO:0010040) |
0.3 | 0.8 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.2 | 1.9 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) ferrous iron transmembrane transport(GO:1903874) |
0.2 | 0.7 | GO:0072343 | pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) |
0.2 | 0.7 | GO:0015867 | ATP transport(GO:0015867) |
0.2 | 1.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) sensory perception of umami taste(GO:0050917) |
0.2 | 0.6 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.2 | 0.8 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.2 | 7.2 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.2 | 0.8 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.2 | 2.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 4.9 | GO:0046688 | response to copper ion(GO:0046688) |
0.2 | 1.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 0.9 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.2 | 0.9 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.2 | 0.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 0.5 | GO:0072276 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.2 | 0.5 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) musculoskeletal movement, spinal reflex action(GO:0050883) |
0.1 | 0.9 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.1 | 4.6 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.1 | 0.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 1.4 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 1.6 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.4 | GO:0071727 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.1 | 4.8 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 1.8 | GO:0015809 | arginine transport(GO:0015809) |
0.1 | 1.0 | GO:0002432 | granuloma formation(GO:0002432) |
0.1 | 6.4 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 0.8 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
0.1 | 1.0 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 1.8 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 2.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.3 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.1 | 0.8 | GO:0032534 | regulation of microvillus assembly(GO:0032534) intestinal epithelial cell development(GO:0060576) |
0.1 | 0.2 | GO:0046271 | coumarin metabolic process(GO:0009804) phenylpropanoid catabolic process(GO:0046271) |
0.1 | 1.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.4 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.1 | 0.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 1.2 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.1 | 0.1 | GO:2000554 | regulation of T-helper 1 cell cytokine production(GO:2000554) positive regulation of T-helper 1 cell cytokine production(GO:2000556) |
0.1 | 2.5 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 2.3 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.5 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.9 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 1.1 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.5 | GO:0009812 | flavonoid metabolic process(GO:0009812) flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.6 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 1.1 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.0 | 0.4 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.0 | 0.3 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.0 | 1.0 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 1.9 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.0 | 0.1 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.0 | 0.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 1.7 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.0 | 0.1 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
0.0 | 0.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
0.0 | 0.2 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 1.3 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.0 | 1.7 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.0 | 0.4 | GO:0045589 | regulatory T cell differentiation(GO:0045066) regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.6 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 0.5 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 6.3 | GO:0008202 | steroid metabolic process(GO:0008202) |
0.0 | 0.4 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 1.8 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.0 | 0.3 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.0 | 2.2 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.1 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.0 | 0.1 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.0 | 0.7 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.4 | GO:0046847 | filopodium assembly(GO:0046847) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.4 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.8 | 7.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.7 | 12.0 | GO:0042581 | specific granule(GO:0042581) |
0.6 | 2.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.5 | 1.5 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 1.1 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
0.4 | 1.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.3 | 1.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 2.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 1.9 | GO:0097433 | dense body(GO:0097433) |
0.2 | 1.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 0.3 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 0.8 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 1.8 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.9 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 1.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 5.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 1.3 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.1 | 0.8 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 0.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 1.3 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 4.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 7.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 16.1 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 4.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 10.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 3.4 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.3 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 | 5.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 4.1 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 6.3 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 0.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.0 | 0.4 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 1.4 | GO:0005901 | caveola(GO:0005901) |
0.0 | 1.0 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 2.5 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 2.1 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.0 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.0 | 4.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.5 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 2.1 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.4 | 51.6 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
2.3 | 6.8 | GO:0045353 | interleukin-1, Type II receptor binding(GO:0005151) interleukin-1 Type I receptor antagonist activity(GO:0045352) interleukin-1 Type II receptor antagonist activity(GO:0045353) |
1.9 | 13.0 | GO:0005499 | vitamin D binding(GO:0005499) |
0.9 | 10.4 | GO:0008199 | ferric iron binding(GO:0008199) |
0.9 | 4.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.7 | 2.2 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.7 | 3.7 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) glycerol channel activity(GO:0015254) |
0.7 | 2.2 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
0.7 | 3.5 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.6 | 1.9 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.6 | 2.5 | GO:0070052 | collagen V binding(GO:0070052) |
0.6 | 4.7 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.5 | 4.8 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.5 | 3.1 | GO:0045340 | mercury ion binding(GO:0045340) |
0.5 | 5.7 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.5 | 4.6 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.5 | 1.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.4 | 4.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.4 | 1.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.4 | 1.1 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
0.3 | 1.4 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.3 | 2.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.3 | 1.3 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 2.2 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.3 | 0.9 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
0.3 | 2.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 17.3 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.3 | 1.8 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 1.4 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 0.8 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.2 | 1.5 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.2 | 14.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 1.0 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.2 | 0.7 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.2 | 1.6 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.2 | 0.6 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 5.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.5 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
0.1 | 0.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 2.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.5 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 1.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 2.6 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 7.8 | GO:0042562 | hormone binding(GO:0042562) |
0.1 | 0.6 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 4.9 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 1.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 3.5 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 0.7 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.1 | 0.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 2.4 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 11.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 5.3 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.6 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 1.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.4 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 2.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.8 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.4 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 2.4 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 1.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 1.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 1.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 1.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 1.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.5 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 1.5 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 3.1 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 2.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.1 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
0.0 | 2.0 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.7 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.0 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.0 | 0.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 2.8 | GO:0005506 | iron ion binding(GO:0005506) |
0.0 | 1.6 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.3 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 1.4 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.1 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.0 | 1.0 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 1.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 12.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 10.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 10.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.8 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 3.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 1.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 9.2 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 2.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 2.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 2.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 19.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 1.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 3.5 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 1.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 20.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 1.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 4.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 1.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 4.6 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 8.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.4 | 12.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.3 | 12.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.3 | 3.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 6.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 4.4 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.2 | 2.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 10.1 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 1.8 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 1.3 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 2.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 4.9 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 1.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 4.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 2.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 3.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 1.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 3.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 1.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 2.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.8 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 1.6 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 2.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 3.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 3.0 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 1.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 1.7 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |